Obesity Treatment Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Obesity Treatment in Global, including the following market information:
Global Obesity Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obesity Treatment market was valued at 5609.9 million in 2021 and is projected to reach US$ 13050 million by 2028, at a CAGR of 12.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical & Implant Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obesity Treatment include NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.) and Apollo Endosurgery (U.S.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obesity Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obesity Treatment Market Segment Percentages, by Type, 2021 (%)
Global Obesity Treatment Market Segment Percentages, by Application, 2021 (%)
Global Obesity Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Obesity Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obesity Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Obesity Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obesity Treatment market was valued at 5609.9 million in 2021 and is projected to reach US$ 13050 million by 2028, at a CAGR of 12.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical & Implant Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obesity Treatment include NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.) and Apollo Endosurgery (U.S.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obesity Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obesity Treatment Market Segment Percentages, by Type, 2021 (%)
- Surgical & Implant Devices
- Medication Therapy
- Dietary
- Other
Global Obesity Treatment Market Segment Percentages, by Application, 2021 (%)
- Children
- Adults
Global Obesity Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Obesity Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obesity Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- NutriSystem, Inc. (U.S.)
- Kellogg Company (U.S.)
- Ethicon, Inc. (U.S.)
- Medtronic (U.S.)
- F. Hoffmann-La Roche (Switzerland)
- Atkins Nutritionals, Inc. (U.S.)
- Herbalife Ltd. (U.S.)
- Covidien plc (U.S.)
- Apollo Endosurgery (U.S.)
- Amer Sports (Finland)
- Johnson Health Technology, Ltd. (Taiwan)
- Cybex International (U.S.)
- USGI Medical (U.S.)
- Olympus Corporation (Japan)
- Brunswick Corporation (U.S.)
- Technogym SpA (Italy)
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Obesity Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Obesity Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OBESITY TREATMENT OVERALL MARKET SIZE
2.1 Global Obesity Treatment Market Size: 2021 VS 2028
2.2 Global Obesity Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Obesity Treatment Players in Global Market
3.2 Top Global Obesity Treatment Companies Ranked by Revenue
3.3 Global Obesity Treatment Revenue by Companies
3.4 Top 3 and Top 5 Obesity Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obesity Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obesity Treatment Players in Global Market
3.6.1 List of Global Tier 1 Obesity Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Obesity Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Obesity Treatment Market Size Markets, 2021 & 2028
4.1.2 Surgical & Implant Devices
4.1.3 Medication Therapy
4.1.4 Dietary
4.1.5 Other
4.2 By Type - Global Obesity Treatment Revenue & Forecasts
4.2.1 By Type - Global Obesity Treatment Revenue, 2017-2022
4.2.2 By Type - Global Obesity Treatment Revenue, 2023-2028
4.2.3 By Type - Global Obesity Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Obesity Treatment Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Obesity Treatment Revenue & Forecasts
5.2.1 By Application - Global Obesity Treatment Revenue, 2017-2022
5.2.2 By Application - Global Obesity Treatment Revenue, 2023-2028
5.2.3 By Application - Global Obesity Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Obesity Treatment Market Size, 2021 & 2028
6.2 By Region - Global Obesity Treatment Revenue & Forecasts
6.2.1 By Region - Global Obesity Treatment Revenue, 2017-2022
6.2.2 By Region - Global Obesity Treatment Revenue, 2023-2028
6.2.3 By Region - Global Obesity Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Obesity Treatment Revenue, 2017-2028
6.3.2 US Obesity Treatment Market Size, 2017-2028
6.3.3 Canada Obesity Treatment Market Size, 2017-2028
6.3.4 Mexico Obesity Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Obesity Treatment Revenue, 2017-2028
6.4.2 Germany Obesity Treatment Market Size, 2017-2028
6.4.3 France Obesity Treatment Market Size, 2017-2028
6.4.4 U.K. Obesity Treatment Market Size, 2017-2028
6.4.5 Italy Obesity Treatment Market Size, 2017-2028
6.4.6 Russia Obesity Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Obesity Treatment Market Size, 2017-2028
6.4.8 Benelux Obesity Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Obesity Treatment Revenue, 2017-2028
6.5.2 China Obesity Treatment Market Size, 2017-2028
6.5.3 Japan Obesity Treatment Market Size, 2017-2028
6.5.4 South Korea Obesity Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Obesity Treatment Market Size, 2017-2028
6.5.6 India Obesity Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Obesity Treatment Revenue, 2017-2028
6.6.2 Brazil Obesity Treatment Market Size, 2017-2028
6.6.3 Argentina Obesity Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Obesity Treatment Revenue, 2017-2028
6.7.2 Turkey Obesity Treatment Market Size, 2017-2028
6.7.3 Israel Obesity Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Obesity Treatment Market Size, 2017-2028
6.7.5 UAE Obesity Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 NutriSystem, Inc. (U.S.)
7.1.1 NutriSystem, Inc. (U.S.) Corporate Summary
7.1.2 NutriSystem, Inc. (U.S.) Business Overview
7.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.1.4 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.1.5 NutriSystem, Inc. (U.S.) Key News
7.2 Kellogg Company (U.S.)
7.2.1 Kellogg Company (U.S.) Corporate Summary
7.2.2 Kellogg Company (U.S.) Business Overview
7.2.3 Kellogg Company (U.S.) Obesity Treatment Major Product Offerings
7.2.4 Kellogg Company (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.2.5 Kellogg Company (U.S.) Key News
7.3 Ethicon, Inc. (U.S.)
7.3.1 Ethicon, Inc. (U.S.) Corporate Summary
7.3.2 Ethicon, Inc. (U.S.) Business Overview
7.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.3.4 Ethicon, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.3.5 Ethicon, Inc. (U.S.) Key News
7.4 Medtronic (U.S.)
7.4.1 Medtronic (U.S.) Corporate Summary
7.4.2 Medtronic (U.S.) Business Overview
7.4.3 Medtronic (U.S.) Obesity Treatment Major Product Offerings
7.4.4 Medtronic (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.4.5 Medtronic (U.S.) Key News
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 F. Hoffmann-La Roche (Switzerland) Corporate Summary
7.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
7.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Major Product Offerings
7.5.4 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann-La Roche (Switzerland) Key News
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Atkins Nutritionals, Inc. (U.S.) Corporate Summary
7.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
7.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.6.4 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.6.5 Atkins Nutritionals, Inc. (U.S.) Key News
7.7 Herbalife Ltd. (U.S.)
7.7.1 Herbalife Ltd. (U.S.) Corporate Summary
7.7.2 Herbalife Ltd. (U.S.) Business Overview
7.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Major Product Offerings
7.7.4 Herbalife Ltd. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.7.5 Herbalife Ltd. (U.S.) Key News
7.8 Covidien plc (U.S.)
7.8.1 Covidien plc (U.S.) Corporate Summary
7.8.2 Covidien plc (U.S.) Business Overview
7.8.3 Covidien plc (U.S.) Obesity Treatment Major Product Offerings
7.8.4 Covidien plc (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.8.5 Covidien plc (U.S.) Key News
7.9 Apollo Endosurgery (U.S.)
7.9.1 Apollo Endosurgery (U.S.) Corporate Summary
7.9.2 Apollo Endosurgery (U.S.) Business Overview
7.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Major Product Offerings
7.9.4 Apollo Endosurgery (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.9.5 Apollo Endosurgery (U.S.) Key News
7.10 Amer Sports (Finland)
7.10.1 Amer Sports (Finland) Corporate Summary
7.10.2 Amer Sports (Finland) Business Overview
7.10.3 Amer Sports (Finland) Obesity Treatment Major Product Offerings
7.10.4 Amer Sports (Finland) Obesity Treatment Revenue in Global Market (2017-2022)
7.10.5 Amer Sports (Finland) Key News
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Johnson Health Technology, Ltd. (Taiwan) Corporate Summary
7.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
7.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Major Product Offerings
7.11.4 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue in Global Market (2017-2022)
7.11.5 Johnson Health Technology, Ltd. (Taiwan) Key News
7.12 Cybex International (U.S.)
7.12.1 Cybex International (U.S.) Corporate Summary
7.12.2 Cybex International (U.S.) Business Overview
7.12.3 Cybex International (U.S.) Obesity Treatment Major Product Offerings
7.12.4 Cybex International (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.12.5 Cybex International (U.S.) Key News
7.13 USGI Medical (U.S.)
7.13.1 USGI Medical (U.S.) Corporate Summary
7.13.2 USGI Medical (U.S.) Business Overview
7.13.3 USGI Medical (U.S.) Obesity Treatment Major Product Offerings
7.13.4 USGI Medical (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.13.5 USGI Medical (U.S.) Key News
7.14 Olympus Corporation (Japan)
7.14.1 Olympus Corporation (Japan) Corporate Summary
7.14.2 Olympus Corporation (Japan) Business Overview
7.14.3 Olympus Corporation (Japan) Obesity Treatment Major Product Offerings
7.14.4 Olympus Corporation (Japan) Obesity Treatment Revenue in Global Market (2017-2022)
7.14.5 Olympus Corporation (Japan) Key News
7.15 Brunswick Corporation (U.S.)
7.15.1 Brunswick Corporation (U.S.) Corporate Summary
7.15.2 Brunswick Corporation (U.S.) Business Overview
7.15.3 Brunswick Corporation (U.S.) Obesity Treatment Major Product Offerings
7.15.4 Brunswick Corporation (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.15.5 Brunswick Corporation (U.S.) Key News
7.16 Technogym SpA (Italy)
7.16.1 Technogym SpA (Italy) Corporate Summary
7.16.2 Technogym SpA (Italy) Business Overview
7.16.3 Technogym SpA (Italy) Obesity Treatment Major Product Offerings
7.16.4 Technogym SpA (Italy) Obesity Treatment Revenue in Global Market (2017-2022)
7.16.5 Technogym SpA (Italy) Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Obesity Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Obesity Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OBESITY TREATMENT OVERALL MARKET SIZE
2.1 Global Obesity Treatment Market Size: 2021 VS 2028
2.2 Global Obesity Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Obesity Treatment Players in Global Market
3.2 Top Global Obesity Treatment Companies Ranked by Revenue
3.3 Global Obesity Treatment Revenue by Companies
3.4 Top 3 and Top 5 Obesity Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obesity Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obesity Treatment Players in Global Market
3.6.1 List of Global Tier 1 Obesity Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Obesity Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Obesity Treatment Market Size Markets, 2021 & 2028
4.1.2 Surgical & Implant Devices
4.1.3 Medication Therapy
4.1.4 Dietary
4.1.5 Other
4.2 By Type - Global Obesity Treatment Revenue & Forecasts
4.2.1 By Type - Global Obesity Treatment Revenue, 2017-2022
4.2.2 By Type - Global Obesity Treatment Revenue, 2023-2028
4.2.3 By Type - Global Obesity Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Obesity Treatment Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Obesity Treatment Revenue & Forecasts
5.2.1 By Application - Global Obesity Treatment Revenue, 2017-2022
5.2.2 By Application - Global Obesity Treatment Revenue, 2023-2028
5.2.3 By Application - Global Obesity Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Obesity Treatment Market Size, 2021 & 2028
6.2 By Region - Global Obesity Treatment Revenue & Forecasts
6.2.1 By Region - Global Obesity Treatment Revenue, 2017-2022
6.2.2 By Region - Global Obesity Treatment Revenue, 2023-2028
6.2.3 By Region - Global Obesity Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Obesity Treatment Revenue, 2017-2028
6.3.2 US Obesity Treatment Market Size, 2017-2028
6.3.3 Canada Obesity Treatment Market Size, 2017-2028
6.3.4 Mexico Obesity Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Obesity Treatment Revenue, 2017-2028
6.4.2 Germany Obesity Treatment Market Size, 2017-2028
6.4.3 France Obesity Treatment Market Size, 2017-2028
6.4.4 U.K. Obesity Treatment Market Size, 2017-2028
6.4.5 Italy Obesity Treatment Market Size, 2017-2028
6.4.6 Russia Obesity Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Obesity Treatment Market Size, 2017-2028
6.4.8 Benelux Obesity Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Obesity Treatment Revenue, 2017-2028
6.5.2 China Obesity Treatment Market Size, 2017-2028
6.5.3 Japan Obesity Treatment Market Size, 2017-2028
6.5.4 South Korea Obesity Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Obesity Treatment Market Size, 2017-2028
6.5.6 India Obesity Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Obesity Treatment Revenue, 2017-2028
6.6.2 Brazil Obesity Treatment Market Size, 2017-2028
6.6.3 Argentina Obesity Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Obesity Treatment Revenue, 2017-2028
6.7.2 Turkey Obesity Treatment Market Size, 2017-2028
6.7.3 Israel Obesity Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Obesity Treatment Market Size, 2017-2028
6.7.5 UAE Obesity Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 NutriSystem, Inc. (U.S.)
7.1.1 NutriSystem, Inc. (U.S.) Corporate Summary
7.1.2 NutriSystem, Inc. (U.S.) Business Overview
7.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.1.4 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.1.5 NutriSystem, Inc. (U.S.) Key News
7.2 Kellogg Company (U.S.)
7.2.1 Kellogg Company (U.S.) Corporate Summary
7.2.2 Kellogg Company (U.S.) Business Overview
7.2.3 Kellogg Company (U.S.) Obesity Treatment Major Product Offerings
7.2.4 Kellogg Company (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.2.5 Kellogg Company (U.S.) Key News
7.3 Ethicon, Inc. (U.S.)
7.3.1 Ethicon, Inc. (U.S.) Corporate Summary
7.3.2 Ethicon, Inc. (U.S.) Business Overview
7.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.3.4 Ethicon, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.3.5 Ethicon, Inc. (U.S.) Key News
7.4 Medtronic (U.S.)
7.4.1 Medtronic (U.S.) Corporate Summary
7.4.2 Medtronic (U.S.) Business Overview
7.4.3 Medtronic (U.S.) Obesity Treatment Major Product Offerings
7.4.4 Medtronic (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.4.5 Medtronic (U.S.) Key News
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 F. Hoffmann-La Roche (Switzerland) Corporate Summary
7.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
7.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Major Product Offerings
7.5.4 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann-La Roche (Switzerland) Key News
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Atkins Nutritionals, Inc. (U.S.) Corporate Summary
7.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
7.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Major Product Offerings
7.6.4 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.6.5 Atkins Nutritionals, Inc. (U.S.) Key News
7.7 Herbalife Ltd. (U.S.)
7.7.1 Herbalife Ltd. (U.S.) Corporate Summary
7.7.2 Herbalife Ltd. (U.S.) Business Overview
7.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Major Product Offerings
7.7.4 Herbalife Ltd. (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.7.5 Herbalife Ltd. (U.S.) Key News
7.8 Covidien plc (U.S.)
7.8.1 Covidien plc (U.S.) Corporate Summary
7.8.2 Covidien plc (U.S.) Business Overview
7.8.3 Covidien plc (U.S.) Obesity Treatment Major Product Offerings
7.8.4 Covidien plc (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.8.5 Covidien plc (U.S.) Key News
7.9 Apollo Endosurgery (U.S.)
7.9.1 Apollo Endosurgery (U.S.) Corporate Summary
7.9.2 Apollo Endosurgery (U.S.) Business Overview
7.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Major Product Offerings
7.9.4 Apollo Endosurgery (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.9.5 Apollo Endosurgery (U.S.) Key News
7.10 Amer Sports (Finland)
7.10.1 Amer Sports (Finland) Corporate Summary
7.10.2 Amer Sports (Finland) Business Overview
7.10.3 Amer Sports (Finland) Obesity Treatment Major Product Offerings
7.10.4 Amer Sports (Finland) Obesity Treatment Revenue in Global Market (2017-2022)
7.10.5 Amer Sports (Finland) Key News
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Johnson Health Technology, Ltd. (Taiwan) Corporate Summary
7.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
7.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Major Product Offerings
7.11.4 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue in Global Market (2017-2022)
7.11.5 Johnson Health Technology, Ltd. (Taiwan) Key News
7.12 Cybex International (U.S.)
7.12.1 Cybex International (U.S.) Corporate Summary
7.12.2 Cybex International (U.S.) Business Overview
7.12.3 Cybex International (U.S.) Obesity Treatment Major Product Offerings
7.12.4 Cybex International (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.12.5 Cybex International (U.S.) Key News
7.13 USGI Medical (U.S.)
7.13.1 USGI Medical (U.S.) Corporate Summary
7.13.2 USGI Medical (U.S.) Business Overview
7.13.3 USGI Medical (U.S.) Obesity Treatment Major Product Offerings
7.13.4 USGI Medical (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.13.5 USGI Medical (U.S.) Key News
7.14 Olympus Corporation (Japan)
7.14.1 Olympus Corporation (Japan) Corporate Summary
7.14.2 Olympus Corporation (Japan) Business Overview
7.14.3 Olympus Corporation (Japan) Obesity Treatment Major Product Offerings
7.14.4 Olympus Corporation (Japan) Obesity Treatment Revenue in Global Market (2017-2022)
7.14.5 Olympus Corporation (Japan) Key News
7.15 Brunswick Corporation (U.S.)
7.15.1 Brunswick Corporation (U.S.) Corporate Summary
7.15.2 Brunswick Corporation (U.S.) Business Overview
7.15.3 Brunswick Corporation (U.S.) Obesity Treatment Major Product Offerings
7.15.4 Brunswick Corporation (U.S.) Obesity Treatment Revenue in Global Market (2017-2022)
7.15.5 Brunswick Corporation (U.S.) Key News
7.16 Technogym SpA (Italy)
7.16.1 Technogym SpA (Italy) Corporate Summary
7.16.2 Technogym SpA (Italy) Business Overview
7.16.3 Technogym SpA (Italy) Obesity Treatment Major Product Offerings
7.16.4 Technogym SpA (Italy) Obesity Treatment Revenue in Global Market (2017-2022)
7.16.5 Technogym SpA (Italy) Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Obesity Treatment Market Opportunities & Trends in Global Market
Table 2. Obesity Treatment Market Drivers in Global Market
Table 3. Obesity Treatment Market Restraints in Global Market
Table 4. Key Players of Obesity Treatment in Global Market
Table 5. Top Obesity Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obesity Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obesity Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obesity Treatment Product Type
Table 9. List of Global Tier 1 Obesity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obesity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obesity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obesity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obesity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obesity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obesity Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obesity Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 30. NutriSystem, Inc. (U.S.) Corporate Summary
Table 31. NutriSystem, Inc. (U.S.) Obesity Treatment Product Offerings
Table 32. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Kellogg Company (U.S.) Corporate Summary
Table 34. Kellogg Company (U.S.) Obesity Treatment Product Offerings
Table 35. Kellogg Company (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Ethicon, Inc. (U.S.) Corporate Summary
Table 37. Ethicon, Inc. (U.S.) Obesity Treatment Product Offerings
Table 38. Ethicon, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Medtronic (U.S.) Corporate Summary
Table 40. Medtronic (U.S.) Obesity Treatment Product Offerings
Table 41. Medtronic (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche (Switzerland) Corporate Summary
Table 43. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offerings
Table 44. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Atkins Nutritionals, Inc. (U.S.) Corporate Summary
Table 46. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offerings
Table 47. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Herbalife Ltd. (U.S.) Corporate Summary
Table 49. Herbalife Ltd. (U.S.) Obesity Treatment Product Offerings
Table 50. Herbalife Ltd. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Covidien plc (U.S.) Corporate Summary
Table 52. Covidien plc (U.S.) Obesity Treatment Product Offerings
Table 53. Covidien plc (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Apollo Endosurgery (U.S.) Corporate Summary
Table 55. Apollo Endosurgery (U.S.) Obesity Treatment Product Offerings
Table 56. Apollo Endosurgery (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Amer Sports (Finland) Corporate Summary
Table 58. Amer Sports (Finland) Obesity Treatment Product Offerings
Table 59. Amer Sports (Finland) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Johnson Health Technology, Ltd. (Taiwan) Corporate Summary
Table 61. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offerings
Table 62. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Cybex International (U.S.) Corporate Summary
Table 64. Cybex International (U.S.) Obesity Treatment Product Offerings
Table 65. Cybex International (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 66. USGI Medical (U.S.) Corporate Summary
Table 67. USGI Medical (U.S.) Obesity Treatment Product Offerings
Table 68. USGI Medical (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Olympus Corporation (Japan) Corporate Summary
Table 70. Olympus Corporation (Japan) Obesity Treatment Product Offerings
Table 71. Olympus Corporation (Japan) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Brunswick Corporation (U.S.) Corporate Summary
Table 73. Brunswick Corporation (U.S.) Obesity Treatment Product Offerings
Table 74. Brunswick Corporation (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Technogym SpA (Italy) Corporate Summary
Table 76. Technogym SpA (Italy) Obesity Treatment Product Offerings
Table 77. Technogym SpA (Italy) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Obesity Treatment Market Opportunities & Trends in Global Market
Table 2. Obesity Treatment Market Drivers in Global Market
Table 3. Obesity Treatment Market Restraints in Global Market
Table 4. Key Players of Obesity Treatment in Global Market
Table 5. Top Obesity Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obesity Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obesity Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obesity Treatment Product Type
Table 9. List of Global Tier 1 Obesity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obesity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obesity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obesity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obesity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obesity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obesity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obesity Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obesity Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obesity Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obesity Treatment Revenue, (US$, Mn), 2023-2028
Table 30. NutriSystem, Inc. (U.S.) Corporate Summary
Table 31. NutriSystem, Inc. (U.S.) Obesity Treatment Product Offerings
Table 32. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Kellogg Company (U.S.) Corporate Summary
Table 34. Kellogg Company (U.S.) Obesity Treatment Product Offerings
Table 35. Kellogg Company (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Ethicon, Inc. (U.S.) Corporate Summary
Table 37. Ethicon, Inc. (U.S.) Obesity Treatment Product Offerings
Table 38. Ethicon, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Medtronic (U.S.) Corporate Summary
Table 40. Medtronic (U.S.) Obesity Treatment Product Offerings
Table 41. Medtronic (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche (Switzerland) Corporate Summary
Table 43. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offerings
Table 44. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Atkins Nutritionals, Inc. (U.S.) Corporate Summary
Table 46. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offerings
Table 47. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Herbalife Ltd. (U.S.) Corporate Summary
Table 49. Herbalife Ltd. (U.S.) Obesity Treatment Product Offerings
Table 50. Herbalife Ltd. (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Covidien plc (U.S.) Corporate Summary
Table 52. Covidien plc (U.S.) Obesity Treatment Product Offerings
Table 53. Covidien plc (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Apollo Endosurgery (U.S.) Corporate Summary
Table 55. Apollo Endosurgery (U.S.) Obesity Treatment Product Offerings
Table 56. Apollo Endosurgery (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Amer Sports (Finland) Corporate Summary
Table 58. Amer Sports (Finland) Obesity Treatment Product Offerings
Table 59. Amer Sports (Finland) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Johnson Health Technology, Ltd. (Taiwan) Corporate Summary
Table 61. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offerings
Table 62. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Cybex International (U.S.) Corporate Summary
Table 64. Cybex International (U.S.) Obesity Treatment Product Offerings
Table 65. Cybex International (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 66. USGI Medical (U.S.) Corporate Summary
Table 67. USGI Medical (U.S.) Obesity Treatment Product Offerings
Table 68. USGI Medical (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Olympus Corporation (Japan) Corporate Summary
Table 70. Olympus Corporation (Japan) Obesity Treatment Product Offerings
Table 71. Olympus Corporation (Japan) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Brunswick Corporation (U.S.) Corporate Summary
Table 73. Brunswick Corporation (U.S.) Obesity Treatment Product Offerings
Table 74. Brunswick Corporation (U.S.) Obesity Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Technogym SpA (Italy) Corporate Summary
Table 76. Technogym SpA (Italy) Obesity Treatment Product Offerings
Table 77. Technogym SpA (Italy) Obesity Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Obesity Treatment Segment by Type in 2021
Figure 2. Obesity Treatment Segment by Application in 2021
Figure 3. Global Obesity Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obesity Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obesity Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obesity Treatment Revenue in 2021
Figure 8. By Type - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obesity Treatment Revenue Market Share, 2017-2028
Figure 12. US Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obesity Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obesity Treatment Revenue Market Share, 2017-2028
Figure 24. China Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obesity Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obesity Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kellogg Company (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ethicon, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medtronic (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Herbalife Ltd. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Covidien plc (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Apollo Endosurgery (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amer Sports (Finland) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cybex International (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. USGI Medical (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Olympus Corporation (Japan) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Brunswick Corporation (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Technogym SpA (Italy) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Obesity Treatment Segment by Type in 2021
Figure 2. Obesity Treatment Segment by Application in 2021
Figure 3. Global Obesity Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obesity Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obesity Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obesity Treatment Revenue in 2021
Figure 8. By Type - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obesity Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obesity Treatment Revenue Market Share, 2017-2028
Figure 12. US Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obesity Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obesity Treatment Revenue Market Share, 2017-2028
Figure 24. China Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obesity Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obesity Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obesity Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kellogg Company (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ethicon, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medtronic (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Herbalife Ltd. (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Covidien plc (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Apollo Endosurgery (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amer Sports (Finland) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cybex International (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. USGI Medical (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Olympus Corporation (Japan) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Brunswick Corporation (U.S.) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Technogym SpA (Italy) Obesity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
